Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 38:1614-1621
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rinfret, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rinfret, S.

CLINICAL STUDY

Quality of life after balloon angioplasty or stenting for acute myocardial infarction

One-year results from the Stent-PAMI trial

Stéphane Rinfret, MD, MSc, FRCP(C)* {dagger}, Cindy L. Grines, MD, FACC§, Roberta S. Cosgrove, MSc, MPH*, Kalon K. L. Ho, MD, MSc, FACC* {dagger}, David A. Cox, MD, FACC||, Bruce R. Brodie, MD, FACC, Marie-Claude Morice, MD, FACC#, Gregg W. Stone, MD, FACC**, David J. Cohen, MD, MSc*,* {dagger} {ddagger} the Stent-PAMI Investigators

* Cardiovascular Data Analysis Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
{dagger} Cardiovascular Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
{ddagger} Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
§ Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan, USA
|| Mid Carolina Cardiology, Charlotte, North Carolina, USA
LeBauer Health Care, Greensboro, North Carolina, USA
# Institut Cardiovasculaire Paris Sud, Antony, France
** Lenox Hill Hospital, New York, New York, USA

Manuscript received March 7, 2001; revised manuscript received July 13, 2001, accepted August 9, 2001.

* Reprint requests and correspondence: Dr. David J. Cohen, Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215 USA
djc{at}hsph.harvard.edu

OBJECTIVES

The goal of this study was to compare the impact of primary stenting or percutaneous transluminal coronary angioplasty (PTCA) on health-related quality of life (HRQOL) in patients undergoing direct angioplasty for acute myocardial infarction (AMI).

BACKGROUND

Previous studies have demonstrated that coronary stenting reduces clinical and angiographic restenosis compared with PTCA. However, the impact of stenting on HRQOL from the patient’s perspective remains unknown.

METHODS

We administered the Seattle Angina Questionnaire and the Medical Outcomes Study Short-form Survey at 1, 6 and 12 months after initial treatment to all North American patients in the Stent-Primary Angioplasty for Myocardial Infarction trial (Stent-PAMI) (n = 509)—a randomized trial comparing primary stenting to conventional PTCA for patients with AMI.

RESULTS

At one month, most HRQOL measures were similar for the two groups, but stent patients reported less bodily pain than PTCA patients (p = 0.03). At six-month follow-up, stenting resulted in significant improvements in several dimensions of HRQOL including reduced anginal frequency and bodily pain as well as improved disease perception (all p ≤ 0.03) and a trend towards better anginal stability (p = 0.056). By 12-month follow-up, however, none of these differences remained statistically significant. These differences in HRQOL were largely explained by the greater need for ischemia-driven target-vessel repeat revascularization procedures in PTCA patients during the first six months (16.0% vs. 6.2%, p < 0.001).

CONCLUSIONS

In patients undergoing revascularization for AMI, initial stent placement is associated with improvements in several dimensions of health status during the first six months of follow-up. In the absence of differences in mortality, these findings add to the overall argument in favor of initial stenting in patients treated with mechanical reperfusion for myocardial infarction.

Abbreviations and Acronyms
  AMI = acute myocardial infarction
  CAD = coronary artery disease
  CCS = Canadian Cardiovascular Society
  COPD = chronic obstructive pulmonary disease
  HRQOL = health-related quality of life
  MI = myocardial infarction
  OPUS = Optimum PTCA compared with Routine Stent Strategy trial
  PCI = percutaneous coronary intervention
  PTCA = percutaneous transluminal coronary angioplasty
  QOL = quality of life
  SAQ = Seattle Angina Questionnaire
  SF-36 = Medical Outcomes Study (MOS) Short-form Survey
  Stent-PAMI = Stent-Primary Angioplasty for Myocardial Infarction trial
  TVR = target-vessel revascularization




This article has been cited by other articles:


Home page
CirculationHome page
J. Ryan and D. J. Cohen
Are Drug-Eluting Stents Cost-Effective?: It Depends on Whom You Ask
Circulation, October 17, 2006; 114(16): 1736 - 1744.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Bakhai, G. W. Stone, E. Mahoney, T. A. Lavelle, C. Shi, R. H. Berezin, B. J. Lahue, M. A. Clark, M. J. Lacey, M. E. Russell, et al.
Cost Effectiveness of Paclitaxel-Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization: Results From the TAXUS-IV Trial
J. Am. Coll. Cardiol., July 18, 2006; 48(2): 253 - 261.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Kim, R. A. Henderson, S. J. Pocock, T. Clayton, M. J. Sculpher, K. A.A. Fox, and RITA-3 Trial Investigators
Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: One-year results of the third randomized intervention trial of unstable angina (RITA-3)
J. Am. Coll. Cardiol., January 18, 2005; 45(2): 221 - 228.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. J. Kernis, K. J. Harjai, G. W. Stone, L. L. Grines, J. A. Boura, W. W. O'Neill, and C. L. Grines
Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1773 - 1779.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Greenberg, A. Bakhai, and D. J. Cohen
Can we afford to eliminate restenosis?: Can we afford not to?
J. Am. Coll. Cardiol., February 18, 2004; 43(4): 513 - 518.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Zhang, E. M. Mahoney, R. H. Stables, J. Booth, F. Nugara, J. A. Spertus, and W. S. Weintraub
Disease-Specific Health Status After Stent-Assisted Percutaneous Coronary Intervention and Coronary Artery Bypass Surgery: One-Year Results From the Stent or Surgery Trial
Circulation, October 7, 2003; 108(14): 1694 - 1700.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. J. Cohen, R. S. Cosgrove, R. H. Berezin, P. S. Teirstein, M. B. Leon, R. E. Kuntz, and on behalf of the Gamma-1 Investigators
Cost-Effectiveness of Gamma Radiation for Treatment of In-Stent Restenosis: Results From the Gamma-1 Trial
Circulation, August 6, 2002; 106(6): 691 - 697.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement